- Home
- NXL vs FLUX Comparison
NXL vs FLUX Comparison
Compare NXL & FLUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- FLUX
- Stock Information
- Founded
- NXL 2010
- FLUX N/A
- Country
- NXL United States
- FLUX United States
- Employees
- NXL N/A
- FLUX N/A
- Industry
- NXL Medical Specialities
- FLUX Industrial Machinery/Components
- Sector
- NXL Health Care
- FLUX Miscellaneous
- Exchange
- NXL Nasdaq
- FLUX Nasdaq
- Market Cap
- NXL 24.2M
- FLUX 20.2M
- IPO Year
- NXL 2022
- FLUX N/A
- Fundamental
- Price
- NXL $1.15
- FLUX $1.86
- Analyst Decision
- NXL Strong Buy
- FLUX Strong Buy
- Analyst Count
- NXL 1
- FLUX 3
- Target Price
- NXL $5.00
- FLUX $6.33
- AVG Volume (30 Days)
- NXL 121.2K
- FLUX 30.3K
- Earning Date
- NXL 05-20-2025
- FLUX 05-08-2025
- Dividend Yield
- NXL N/A
- FLUX N/A
- EPS Growth
- NXL N/A
- FLUX N/A
- EPS
- NXL N/A
- FLUX N/A
- Revenue
- NXL $168,721.00
- FLUX $60,789,000.00
- Revenue This Year
- NXL $79.59
- FLUX $11.85
- Revenue Next Year
- NXL $334.65
- FLUX $13.10
- P/E Ratio
- NXL N/A
- FLUX N/A
- Revenue Growth
- NXL 52.35
- FLUX N/A
- 52 Week Low
- NXL $0.53
- FLUX $1.15
- 52 Week High
- NXL $4.49
- FLUX $4.98
- Technical
- Relative Strength Index (RSI)
- NXL 22.27
- FLUX 59.36
- Support Level
- NXL $1.75
- FLUX $1.67
- Resistance Level
- NXL $1.39
- FLUX $1.98
- Average True Range (ATR)
- NXL 0.13
- FLUX 0.16
- MACD
- NXL -0.05
- FLUX 0.03
- Stochastic Oscillator
- NXL 0.01
- FLUX 77.36
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.